ArticleBiotechnology letters2025
Optimization of esterification reactions of perillyl alcohol with different fatty acids catalyzed by Novozym® 435 lipase.
Article in Biotechnology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Perillyl alcohol is a monoterpene known for its potent antitumor activity. In this study, we focused on esterification reactions of perillyl alcohol catalyzed by the immobilized enzyme Novozym 435 from Pseudozyma antarctica. Initially, the reaction conditions using a molar ratio of 1:4 (2:5 mmol of monoterpene: 10 mmol of octanoic acid), 40 mg of Novozym 435, 30 °C, and 150 rpm, 10 mL of cyclohexane, resulted in conversions up to 90% by 24 h. To explore the impact of different fatty acid carbon chain lengths on conversion, we conducted reactions with fatty acids containing chain lengths with 3, 6, 8, 12, and 18 carbons, evaluating the impact of the molar ratio of monoterpene:fatty acid. The observed impacts on conversion led to the categorization of fatty acids into two groups: the first group (C
Indexed as
Identifiers
40192831What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.